|
|
|
Volumn 16, Issue 9 Suppl 9, 2002, Pages 39-43
|
|
Irinotecan plus cisplatin in small-cell lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CISPLATIN;
DRUG DERIVATIVE;
IRINOTECAN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
HUMAN;
LUNG TUMOR;
MORTALITY;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SMALL CELL CARCINOMA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CARCINOMA, SMALL CELL;
CISPLATIN;
CLINICAL TRIALS, PHASE III;
DISEASE-FREE SURVIVAL;
HUMANS;
LUNG NEOPLASMS;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0036731292
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (24)
|
